The article presents information on a case study that was conducted to assess whether adjuvant chemotherapy increases survival rate in patients with resected colorectal cancer. About 3239 patients in the age group of 23 and 86 were included in the study. The study reveals that chemotherapy reduces risk for all outcomes. Most of the benefit was seen in the first 2 years.